P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -167.86 Million USD | 89.25% |
| 2022 | -1.56 Billion USD | 95.03% |
| 2021 | -31.41 Billion USD | -89339.0% |
| 2020 | -35.12 Million USD | 11.17% |
| 2019 | -39.53 Million USD | 20.47% |
| 2018 | -49.71 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -43.83 Million USD | 31.79% |
| 2024 Q2 | -31.33 Million USD | 28.51% |
| 2023 FY | -167.86 Million USD | 89.25% |
| 2023 Q2 | -21.03 Million USD | 56.91% |
| 2023 Q4 | -64.26 Million USD | -90.01% |
| 2023 Q3 | -33.82 Million USD | -60.79% |
| 2023 Q1 | -48.81 Million USD | 90.9% |
| 2022 FY | -1.56 Billion USD | 95.03% |
| 2022 Q4 | -536.5 Million USD | -793.99% |
| 2022 Q3 | -60.01 Million USD | 93.42% |
| 2022 Q2 | -912.18 Million USD | -1648.57% |
| 2022 Q1 | -52.16 Million USD | -186.16% |
| 2021 Q1 | -12.98 Million USD | -203.42% |
| 2021 FY | -31.41 Billion USD | -89339.0% |
| 2021 Q4 | 60.55 Million USD | 315.3% |
| 2021 Q3 | -28.12 Million USD | -44.68% |
| 2021 Q2 | -19.43 Million USD | -49.66% |
| 2020 Q4 | -4.28 Million USD | 68.33% |
| 2020 Q2 | -4.66 Million USD | 23.93% |
| 2020 Q1 | -6.12 Million USD | 0.0% |
| 2020 Q3 | -13.51 Million USD | -189.85% |
| 2020 FY | -35.12 Million USD | 11.17% |
| 2019 FY | -39.53 Million USD | 20.47% |
| 2018 FY | -49.71 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 133.135% |
| Addus HomeCare Corporation | 90.95 Million USD | 284.551% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 1870.115% |
| Amedisys, Inc. | 156.39 Million USD | 207.331% |
| American Oncology Network, Inc. | -49.15 Million USD | -241.498% |
| Astrana Health, Inc. | 84.61 Million USD | 298.386% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 2179.534% |
| IMAC Holdings, Inc. | -6.37 Million USD | -2532.888% |
| biote Corp. | 28.65 Million USD | 685.756% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -1264.268% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 248.927% |
| COMPASS Pathways plc | -136.91 Million USD | -22.598% |
| DocGo Inc. | 15.05 Million USD | 1214.98% |
| The Ensign Group, Inc. | 255.36 Million USD | 165.733% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 369.188% |
| InnovAge Holding Corp. | -23.18 Million USD | -624.159% |
| Assure Holdings Corp. | -20.08 Million USD | -735.873% |
| The Joint Corp. | -2.07 Million USD | -7997.103% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 11.248% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -968.917% |
| ModivCare Inc. | -139.94 Million USD | -19.946% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 397477.018% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -1862.549% |
| Option Care Health, Inc. | 314.59 Million USD | 153.357% |
| P3 Health Partners Inc. | -167.86 Million USD | -0.0% |
| The Pennant Group, Inc. | 25.16 Million USD | 766.932% |
| Surgery Partners, Inc. | 328 Million USD | 151.177% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -5713.134% |
| Talkspace, Inc. | -23.2 Million USD | -623.254% |
| Talkspace, Inc. | -23.2 Million USD | -623.254% |
| The Oncology Institute, Inc. | -77.01 Million USD | -117.949% |
| The Oncology Institute, Inc. | -77.01 Million USD | -117.949% |